[{"indications": "Indications\u00a0postoperative urinary retention (see\r\nnotes above), neurogenic bladder; myasthenia gravis (section 10.2.1)", "name": "DISTIGMINE BROMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "7 Obstetrics, gynaecology, and urinary-tract disorders", "7.4 Drugs for genito-urinary disorders", "7.4.1 Drugs for urinary retention", "Parasympathomimetics"], "cautions": "Cautions\u00a0peptic ulcer; conditions where increased motility of the urinary or gastro-intestinal\r\ntract could be harmful; oesophagitis; cardiovascular\r\ndisease; bronchospasm; epilepsy; parkinsonism; interactions: Appendix 1 (parasympathomimetics)", "side-effects": "Side-effects\u00a0abdominal pain, diarrhoea, increased salivation;\r\nbradycardia, AV block, hypotension; dyspnoea; muscle twitching; increased\r\nlacrimation, miosis; increased sweating", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4627.htm", "doses": ["Urinary retention, 5\u00a0mg daily, half an hour before breakfast", "Neurogenic bladder, 5\u00a0mg daily or on alternate days, half an\r\nhour before breakfast"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid (may stimulate uterine\r\ncontractions)"}]